Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan · Delayed Price · Currency is JPY 250.00
+2.00 (0.81%)
Aug 4, 2026, 12:34 PM JST
Taiko Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,163 | 6,397 | 6,292 | 6,120 | 5,040 | 11,299 |
Revenue Growth | 1.62% | 1.67% | 2.81% | 21.43% | -55.39% | -49.68% |
Gross Profit Gross Profit Growth | 3,303 | 3,481 | 3,666 | 2,577 | 1,079 | 2,747 |
Operating Income Operating Income Growth | 317 | 459 | 630 | -1,006 | -3,078 | -4,947 |
Net Income Net Income Growth | 536 | 923 | 898 | -3,611 | -4,895 | -9,594 |
Earnings Per Share EPS Growth | 10.67 | 18.37 | 17.89 | -76.25 | -112.27 | -220.51 |
EPS Growth | -25.43% | 2.67% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Business Pharmaceutical Business Growth | 5,640 | 5,771 | 5,778 | 5,185 | 3,624 | 4,350 |
Infection Control Business Infection Control Business Growth | 515 | 619 | 508 | 929 | 1,408 | 6,942 |
Others Business Others Business Growth | 5 | 5 | 5 | 5 | 7 | 6 |
Total Total Growth | 6,160 | 6,395 | 6,291 | 6,119 | 5,039 | 11,298 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,832 | 4,256 | 4,532 | 5,484 | 3,505 | 6,098 |
Total Debt Total Debt Growth | 421 | 816 | 2,027 | 3,254 | 3,809 | 4,773 |
Net Cash (Debt) Net Cash Growth | 3,411 | 3,440 | 2,505 | 2,230 | -304 | 1,325 |
Net Cash Growth | 11.98% | 37.33% | 12.33% | - | - | -72.68% |
Net Cash Per Share Net Cash Per Share Growth | 67.88 | 68.48 | 49.92 | 47.09 | -6.97 | 30.45 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 814 | 362 | -307 | -1,994 | -1,595 |
Capital Expenditures CapEx Growth | - | -291 | -157 | -97 | -64 | -1,476 |
Free Cash Flow Free Cash Flow Growth | - | 523 | 205 | -404 | -2,058 | -3,071 |
Free Cash Flow Growth | - | 155.12% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 53.59% | 54.42% | 58.26% | 42.11% | 21.41% | 24.31% |
Operating Margin | 5.14% | 7.17% | 10.01% | -16.44% | -61.07% | -43.78% |
Pretax Margin | 8.05% | 14.96% | 9.00% | -58.24% | -96.63% | -78.66% |
Profit Margin | 8.70% | 14.43% | 14.27% | -59.00% | -97.12% | -84.91% |
FCF Margin | - | 8.18% | 3.26% | -6.60% | -40.83% | -27.18% |
| Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 3.500 | 3.300 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 1.38% | 1.11% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.25 | 16.22 | 18.50 | - | - | - |
Forward PE | 127.84 | 56.76 | 27.36 | 41.47 | 41.47 | 41.47 |
P/FCF Ratio | 23.83 | 28.63 | 81.04 | - | - | - |
PS Ratio | 2.02 | 2.34 | 2.64 | 2.46 | 3.41 | 3.18 |